Intervention in infants with cystic fibrosis key to slowing p... ( Early detection of lung disease in c...)

Intervention in infants with cystic fibrosis key to slowing progression

Date:12/4/2008

Early detection of lung disease in cystic fibrosis (CF), combined with aggressive treatment in infants, may be the key to controlling the progression of the disease, according to a recent study. New research shows that contrary to previous scientific opinion, progressive lung damage in CF patients can begin as early as infancy even though lung function shortly after diagnosis is normal.

"We might be able to stop some of the lung function reduction we're identifying in the first months of life," said Dr. Sarath Ranganathan, Ph.D., consultant respiratory physician at the Royal Children's Hospital in Melbourne, and lead author of the paper, which appeared in the second issue for December of the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

"We don't know what's going to work, but we have to target those patients in the first six months of life if we're going to be effective," added Dr. Ranganathan.

In the Australian study, 68 infants with CF were compared to 49 infants without the disease. The children were between six weeks and 30 months of age. Forced expiratory volume (FEV) measurements were obtained for the children at baseline, and 16 of the children with CF were measured again one year later. FEV was equivalent for all children both with and without CF at baseline. But by six months of age, the mean FEV score was significantly lower in infants with CF compared to controlsand the deficit increased with each month of age. "This finding indicates that lung function declines sooner than previously thought," said Dr. Ranganathan.

The study also found that diminished lung function occurred even in the absence of clinical symptoms and irrespective of CF genotype. But, notably, infants measured soon after birth and within the first six months of life had normal lung function. Newborn screening for CF has been in existence in Australia for nearly 30 years, but was introduced only r
'/>"/>

Contact: Keely Savoie
ksavoie@thoracic.org
212-315-8620
American Thoracic Society
Source:Eurekalert

0

GOOD

Page: 1 2 3
Related medicine news :

1. Posit Science Invited to Speak at Johns Hopkins University About Cutting Edge Cognitive Training Interventions
2. Elseviers New Imaging Consult Features In-Depth, Authoritative Information For Diagnostic and Interventional Imaging and Procedures in a Single Online Resource
3. HealthMedia Announces Industrys First Individually Tailored Physical Activity Intervention and Other Innovative New Program Features
4. Home-based diet and exercise intervention improves elderly cancer survivors physical function
5. Intervention program boosts survival in breast cancer patients
6. Psychological interventions associated with breast cancer survival
7. Rubenstein Public Relations to Launch National Campaign for The American Society of Interventional Pain Physicians
8. New model developed to estimate radiation skin doses during CT-guided interventional procedures
9. Interventions to Promote Breast-Feeding Succeed
10. The future of interventional cardiology presented at TCT 2008
11. 2nd International Conference, Signs of Autism in Infants: Changing Outcomes Through Early Identification and Intervention, October 11 & 12, 2008; Unique and Critical Event

Post Your Comments:

(Date:12/15/2009)... Accelify is proud to announce the addition ... David will serve as Director of Development in the ... Board of Advisors. ,, David Tokofsky was ... of Education in June 1995. As the Board Member ... 600,000 stretching from Northeast Los Angeles through East Los ...

(Date:12/15/2009)... Reportlinker.com announces that a ... in its catalogue: ,, The ... Market Forecasts to 2015, Competitive Benchmarking, ... ,, http://www.reportlinker.com/p0168098/The-Future-of-Cardiovascular-Diseases-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ,, ... released its latest research "The Future ...

(Date:12/15/2009)... Dec. 15 Hospira, Inc. (NYSE: ... in generic injectable pharmaceuticals, and Orchid Chemicals ... a leading Indian pharmaceuticals company and among ... today announced an agreement for Hospira to ... business for approximately $400 million. ,, ...

(Date:12/15/2009)... Visits to a gynaecologist or midwife are generally ... but could offer so much more. Women, doctors ... great opportunities for dialogue about sexual health, reveals ... University of Gothenburg, Sweden. , Many young women ... Almost 500 women aged 23-29 answered questions about ...

(Date:12/15/2009)... seen as a potential heart disease therapy, raising high-density ... transfer protein may not be effective, a new study ... Research Center on Aging (USDA HNRCA) at Tufts University ... association between low plasma cholesterol ester transfer protein (CETP) ... Framingham Heart Study population. , CETP is a protein ...

[0] Accelify Announces the Addition of David Tokofsky to its National Board of Advisors [0] Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis [0] Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business [0] More about sex and relationships needed at gynecological visits [0] Low cholesterol transfer protein activity associated with heart disease risk

... ... Offering, LAKEWOOD, N.J., ... a national gastrointestinal (GI),offering to further expand its diagnostic services. The ... a regional laboratory into a national anatomic pathology leader,offering a range ...

... 19 Align Technology,Inc. (Nasdaq: ALGN ), today ... president of research and development, effective June 16. Mr. ... Officer, Thomas,M. Prescott and lead the Company,s research and ... and we are pleased to,have Dana on board to ...

... Minneapolis-St. Paul, DC and San,Francisco as Most Heart Friendly ... the No. 1,killer of women, may hit closer to ... Red For Women movement released a study,conducted by Sperling,s ... heart friendly cities for women. Minneapolis-St. Paul took the,title ...

... May 19 Chiltern, a leading global research,organization, announced ... of,General Manager, Latin America., The Latin American operation ... Podesta and will be primarily focused on supporting our,Global ... 9,years experience in clinical research, where he has held ...

... happen to men, not only to women, according to Group ... Domestic violence in men is under-studied and often hiddenmuch as ... Robert J. Reid, MD, PhD, an associate investigator at the ... to know theyre not alone. His findings confirm some common ...

... ... Defy Economic Downturn and Remind Policy Makers that AIDS is Still ... a Crisis at Home., NEW YORK, May ... and most successful AIDS Walk,ever held, setting a fundraising record even in the face of ...

Other Medicine News:Health News:Lakewood Pathology Launches National Gastroinestinal Diagnostic Services 2 Health News:Align Technology Names Dana C. Cambra as VP, Research & Development 2 Health News:American Heart Association Ranks America's Most Heart Friendly Cities for Women 2 Health News:American Heart Association Ranks America's Most Heart Friendly Cities for Women 3 Health News:American Heart Association Ranks America's Most Heart Friendly Cities for Women 4 Health News:American Heart Association Ranks America's Most Heart Friendly Cities for Women 5 Health News:Chiltern Expands Its Global Reach to Latin America 2 Health News:Men experience domestic violence, with health impact 2 Health News:AIDS Walk New York Raises $7.05 Million 2

Lakewood Pathology Launches National Gastroinestinal Diagnostic Services Align Technology Names Dana C. Cambra as VP, Research & Development American Heart Association Ranks America's Most Heart Friendly Cities for Women Chiltern Expands Its Global Reach to Latin America Men experience domestic violence, with health impact AIDS Walk New York Raises $7.05 Million

(Date:12/15/2009)... CITY, Dec. 15 Dynatronics ... signed a preferred vendor agreement to provide therapy ... Inc. (PTP), a nationwide network of physical, occupational ... be working with Preferred Therapy Providers," said Larry ... marketing at Dynatronics. "Their vast network of 1,100 ...

(Date:12/15/2009)... Dec. 15 ,, Reportlinker.com announces ... available in its catalogue: ,, Hepatitis ... Forecasts to 2015 ,, http://www.reportlinker.com/p0167309/Hepatitis-B-Vaccines---Pipeline-Analysis-and-Market-Forecasts-to-2015.html ... Analysis and Market Forecasts to 2015 ,, ... analysis specialist,s new report, "Hepatitis B Vaccines ...

(Date:12/15/2009)... NEW YORK, Dec. 15 Reportlinker.com ... is available in its catalogue: ,, ... http://www.reportlinker.com/p0168539/Boehringer-Ingelheim-GmbH-PharmaVitae-Profile.html ,, Introduction ... forecast performance for Boehringer Ingelheim in the ... strategy, portfolio and pipeline analysis and assessment ...

Breaking Medicine Technology:Dynatronics Inks Preferred Vendor Agreement with 1,100 Member Preferred Therapy Providers, Inc. 2 Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 2 Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 3 Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 4 Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 5 Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 6 Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 7 Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 2 Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 3 Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 4 Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 5 Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 6 Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 7 John Hancock Announces Enhancements to Group Long Term Care 28LTC 29 Insurance Products and Discount Program 49216 1 John Hancock Announces Enhancements to Group Long Term Care 28LTC 29 Insurance Products and Discount Program 49216 2 John Hancock Announces Enhancements to Group Long Term Care 28LTC 29 Insurance Products and Discount Program 49216 3 John Hancock Announces Enhancements to Group Long Term Care 28LTC 29 Insurance Products and Discount Program 49216 4 Accelerated Development of New Treatment for Multi Drug Resistant Tuberculosis 3A TB Alliance and Tibotec Announce Unique Partnership to Develop TMC20 49213 1 Accelerated Development of New Treatment for Multi Drug Resistant Tuberculosis 3A TB Alliance and Tibotec Announce Unique Partnership to Develop TMC20 49213 2 Accelerated Development of New Treatment for Multi Drug Resistant Tuberculosis 3A TB Alliance and Tibotec Announce Unique Partnership to Develop TMC20 49213 3 New Study Finds 1 in 4 Multiple Sclerosis Patients With High Out of Pocket Costs Not Filling Prescriptions 49210 1 New Study Finds 1 in 4 Multiple Sclerosis Patients With High Out of Pocket Costs Not Filling Prescriptions 49210 2

[0] Dynatronics Inks Preferred Vendor Agreement with 1,100 Member Preferred Therapy Providers, Inc.[0] Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 [0] Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile

... fMRI Study Completed and Reported Today ... Higher Repeat Dose Study Completed, HAMBURG, Germany and ... EVT) is pleased to announce the,preliminary findings of a ... subtype selective NMDA receptor antagonist, EVT,101. The study was ...

... Study Highlights Growing Therapeutic Value of Cord Blood ... Stems cells derived,from umbilical cord blood are showing ... from a new preclinical study,published in the March ... by researchers from the University of South Florida ...

Other Medicine Technology:Evotec's EVT 101 Shown to Penetrate the Brain in Man and to Modulate Brain Activity During the Performance of Cognitive Tasks 2 Evotec's EVT 101 Shown to Penetrate the Brain in Man and to Modulate Brain Activity During the Performance of Cognitive Tasks 3 Early Research Suggests Umbilical Cord Blood Cell Therapy May Reduce Progression of Alzheimer's Disease 2 Early Research Suggests Umbilical Cord Blood Cell Therapy May Reduce Progression of Alzheimer's Disease 3 Early Research Suggests Umbilical Cord Blood Cell Therapy May Reduce Progression of Alzheimer's Disease 4 Early Research Suggests Umbilical Cord Blood Cell Therapy May Reduce Progression of Alzheimer's Disease 5

Evotec's EVT 101 Shown to Penetrate the Brain in Man and to Modulate Brain Activity During the Performance of Cognitive Tasks Early Research Suggests Umbilical Cord Blood Cell Therapy May Reduce Progression of Alzheimer's Disease

Solid 15 mm blades with 8 mm narrowed portion. Screw-controlled locking mechanism with stabilizing disk. Dull finish....

Pediatric model. Spring-controlled spread of blades with locking mechanism. Dull finish. Blades: 11 mm....

Adult model. Spring-controlled spread of blades with locking mechanism. Dull finish. Blades: 14 mm....

Solid 14 mm free-swinging blades, suture posts, and stabilizing disk. Dull finish....

Medicine Products:

Keizer-Lancaster Eye Speculum Williams Eye Speculum - 11 mm Williams Eye Speculum - 14 mm McPherson Speculum

Intervention in infants with cystic fibrosis key to slowing p...( Early detection of lung disease in c...),Health